Schizophrenia Clinical Trial
Official title:
Schizophrenia for "Life" - a Registry and Interview Study Among Elderly With Lifelong Schizophrenia
Verified date | July 2018 |
Source | University of Southern Denmark |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The elderly demographic is on the rise - and this includes elderly living with schizophrenia.
Yet very little is known about their lives, how they cope with their condition and how it
develops over time.
Research in this patient-group is sparse; overall there seem to be a tendency for elderly
patients to manifest fewer psychotic symptoms and experiencing an increase in the
psychological quality of life with older age. Opinions are divided on the degree and extent
to which this tendency reflects remission and/or recovery in older patients.
In order to identify factors associated with a positive outcome we:
- Investigate the course and the outcomes of the illness over the lifespan, as well as the
life course and outcomes.
- Investigate the current status of mental and physical health, quality of life as well as
functional competence of elderly (55+ yr) with schizophrenia.
Also the investigators
- Compare the trajectory and prognosis of schizophrenia (a chronic mental illness) with type
1 diabetes (a chronic somatic illness).
This study will yield vital insights into how schizophrenia develops over time, isolating
factors that determine how well patients fare. The perspective is to advance knowledge of
elderly with schizophrenia with a view to optimizing and increasing the effectiveness of the
interventions offered to this group.
Status | Completed |
Enrollment | 10404 |
Est. completion date | December 2017 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 55 Years to 95 Years |
Eligibility |
Inclusion Criteria: Initial schizophrenia diagnosis between the ages 18-40 (both incl) in the period 1970-1979 (both incl) Interview study: Residence in Region of Southern Denmark Exclusion Criteria: Interview study: Mental retardation |
Country | Name | City | State |
---|---|---|---|
Denmark | Research Unit of Psychiatry, Psychiatric Unit Odense - University function | Odense C |
Lead Sponsor | Collaborator |
---|---|
Kjeld Andersen | Butcher Max Wørzner and wife Inger Wørzner's Memorial Grant, Jeppe Juhl and Ovita Juhls Memorial Grant, Odense Patient Data Explorative Network, Region of Southern Denmark, The Danish Health Foundation (Helsefonden), The Danish Mental Health Foundation (Psykiatrifonden), The non-profit foundation Trygfonden., The Psychiatric Research Foundation in Southern Denmark, University of Southern Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Ageing with schizophrenia | Prognosis measured by use of healthcare system, use of medicine, co-morbidity, mortality, causes of mortality, and socio-demographic data, including highest level of education, years of employment/un-employment, use of health- and welfare services. | up to 45 years | |
Secondary | Quality of life | Questionnaire | 1 month | |
Secondary | Remission | Questionnaire | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |